Company intelligence / Profile preview

Saccadous

Scottsdale, Arizona, United States

Ownership: Private
Development stage: Other

Overview

Saccadous has developed a non-invasive cloud-based platform that detects and tracks neurological disorders through eye movement analysis. The company is conducting research studies in collaboration with established medical institutions, including investigations with The Muhammad Ali Parkinson Center at Barrow Neurological Institute.

Therapeutic areas: PsychiatryNeurology
Modalities: Device (eye tracking technology)Software/Analytics platform
Industry: Physiological Monitoring

Partnerships

The Muhammad Ali Parkinson Center at Barrow Neurological InstituteSystems Imagination, Inc. (eye tracking technology partnership)SMART Brain Aging, Inc. (MCI research collaboration)

Beyond the preview

Go deeper on Saccadous.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saccadous.

Explore the full profile